When it does happen, the sky's the limit for this stock. It's one of very few real companies on the OTC, with verifiable products and no dilution for over 3 years. Fred's illness was untimely, but they are working on it and will get it done. Regarding stagnancy, mostly true. The price did run to 3.5 cents last year on merger news, and again to 2.4 cents this year. Looking forward to blue skies this year.

Quote:

---

And until that happens, all we will see is a stagnant pps. Which has been the case for several years now.

---